Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension.
RMD Open
; 7(3)2021 09.
Article
de En
| MEDLINE
| ID: mdl-34548383
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Rachitisme hypophosphatémique familial
Type d'étude:
Clinical_trials
/
Prognostic_studies
Aspects:
Patient_preference
Limites:
Adult
/
Humans
Langue:
En
Journal:
RMD Open
Année:
2021
Type de document:
Article
Pays d'affiliation:
France